Cargando…
Measurement of Low‐Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM Registry
BACKGROUND: The 2013 American College of Cardiology/American Heart Association Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults recommended testing low‐density lipoprotein cholesterol (LDL‐C) to identify untreated patients with LDL‐C ≥190 mg/dL,...
Autores principales: | Lowenstern, Angela M., Li, Shuang, Navar, Ann Marie, Roger, Veronique L., Robinson, Jennifer G., Goldberg, Anne C., Virani, Salim S., Lee, L. Veronica, Wilson, Peter W. F., Louie, Michael J., Peterson, Eric D., Wang, Tracy Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222939/ https://www.ncbi.nlm.nih.gov/pubmed/30371214 http://dx.doi.org/10.1161/JAHA.118.009251 |
Ejemplares similares
-
Patient perceptions and use of non‐statin lipid lowering therapy among patients with or at risk for atherosclerotic cardiovascular disease: Insights from the PALM registry
por: Lowenstern, Angela, et al.
Publicado: (2021) -
Patient‐Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry
por: Bradley, Corey K., et al.
Publicado: (2019) -
Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry
por: Nanna, Michael G., et al.
Publicado: (2018) -
Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry
por: Xian, Ying, et al.
Publicado: (2019) -
Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
por: Sniderman, Allan D., et al.
Publicado: (2016)